Article Text
Letter
Severe polyneuropathy complicating active Crohn’s disease: rapid response to Infliximab
Statistics from Altmetric.com
Treatment with a chimeric antitumour necrosis factor (TNF) antibody (Infliximab) has been shown to be highly efficient for patients with steroid refractory Crohn’s disease (CD).1 However, the mechanism of action remains largely unknown.2 Recently, a favourable response to Infliximab treatment was demonstrated in some diseases complicating active CD such as acute idiopathic pancreatitis.3 We report a case of a middle aged female with CD that developed an aggressive form of polyneuritis resistant to corticosteroids.
A 55 year …